HIMS - Hims & Hers Health, Inc.

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 13.65

Open

Bid

$ 13.64 x 300

Ask

$ 13.65 x 100

Day's Range

-- - --

52 Week Range

$ 5.65 - $ 25.74

Volume

9,235,427

Average Volume

Market Cap

2.96B

Beta (5Y Monthly)

$ 0.90

PE Ratio (TTM)

$ 164.08

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2024	06-30-2024	10-Q
2	05-06-2024	03-31-2024	10-Q
3	02-26-2024	12-31-2023	10-K
4	11-06-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	02-27-2023	12-31-2022	10-K
8	11-07-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-11-2021	06-30-2021	10-Q
14	05-17-2021	03-31-2021	10-Q
15	03-22-2021	12-31-2020	10-K
16	11-13-2020	09-30-2020	10-Q
17	08-13-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	03-27-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-29-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

battle-over-compounded-weight-loss-medications---sustainability-and-regulation

Battle Over Compounded Weight-Loss Medicat...
09/05/2024 16:47:47

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing ...

MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters

Hearing Blog Post; Capitol Forum Reports F...
08/29/2024 19:09:36

Why Hims & Hers Health Stock Is Falling
08/27/2024 14:54:44

Eli Lilly's launch of the competitively priced Zepbound has triggered a 4.9% drop in Hims & Hers' stock. This has r...

american-woodmark-reports-downbeat-results-joins-snowflake-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

American Woodmark Reports Downbeat Results...
08/27/2024 12:12:10

hims--hers-health-sees-major-growth-opportunity-in-booming-weight-loss-market-says-analyst

Hims & Hers Health Sees Major Growth Oppor...
08/22/2024 18:26:20

Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive...

The Latest Analyst Ratings For Hims & Hers...
08/22/2024 14:00:22

Hims & Hers Health shares are trading high...
08/22/2024 12:55:24

Needham Initiates Coverage On Hims & Hers ...
08/22/2024 11:01:36

Needham analyst Ryan MacDonald initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announces Pric...

looking-into-hims--hers-healths-recent-short-interest

Looking Into Hims & Hers Health's Recent S...
08/19/2024 19:15:18

telehealth-firm-hims--hers-health-rides-high-on-demand-for-copycat-weight-loss-drugs-amid-supply-shortages

Telehealth Firm Hims & Hers Health Rides H...
08/19/2024 13:24:02

Hims & Hers Health has seen its stock rise over 120% due to soaring demand for its affordable compounded GLP-1 weight-loss ...

hims--hers-health-unusual-options-activity-for-august-13

Hims & Hers Health Unusual Options Activit...
08/13/2024 15:47:11

Deutsche Bank Maintains Hold on Hims & Her...
08/07/2024 17:31:07

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from ...

Analyst Expectations For Hims & Hers Healt...
08/06/2024 20:01:49

Piper Sandler Reiterates Neutral on Hims &...
08/06/2024 17:51:38

Piper Sandler analyst Korinne Wolfmeyer reiterates Hims & Hers Health (NYSE:HIMS) with a Neutral and maintains $18 price...

Top 10 Trending Stocks On WallStreetBets A...
08/06/2024 13:19:31

NVDAWAYINTCAAPLMADELOTHIMSPLTRQQQTSLAData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment NVDAWAYINTCA...

hims--hers-health-reports-better-than-expected-q2-results-details

Hims & Hers Health Reports Better-Than-Exp...
08/05/2024 20:26:43

Hims & Hers Health reported its second-quarter financial results Monday. Here's a look at the details from the report.

Hims & Hers Health Expects Q3 Revenue Of $...
08/05/2024 20:21:44

Adjusted EBITDA of $35 million to $40 million, reflecting an Adjusted EBITDA margin of 9% to 11%.

Hims & Hers Health Raises FY24 Revenue Gui...
08/05/2024 20:20:15

Raises full year 2024 Adjusted EBITDA guidance to a range of $140 million to $155 million

Hims & Hers Health Q2 2024 GAAP EPS $0.06 ...
08/05/2024 20:07:59

Hims & Hers Health (NYSE:HIMS) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of ...